Does an increase in serum creatinine from 0.8 mg/dL to 1.8 mg/dL meet the criteria for acute kidney injury (AKI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Yes, an increase in serum creatinine from 0.8 to 1.8 mg/dL definitively meets the criteria for acute kidney injury (AKI).

This represents a 125% increase from baseline (1.8/0.8 = 2.25 times baseline), which classifies as KDIGO Stage 2 AKI if this rise occurred within 7 days. 1

How the KDIGO Criteria Apply

According to the KDIGO guidelines, AKI is diagnosed when any of the following occur 1, 2:

  • Stage 1: Rise of ≥0.3 mg/dL within 48 hours OR 50-99% increase from baseline within 7 days (1.5-1.99× baseline)
  • Stage 2: 100-199% increase from baseline within 7 days (2.0-2.99× baseline)
  • Stage 3: ≥200% increase from baseline within 7 days (≥3.0× baseline) OR creatinine ≥4.0 mg/dL with appropriate rise

Your Specific Case Analysis

Your creatinine rise from 0.8 to 1.8 mg/dL represents:

  • Absolute increase: 1.0 mg/dL (far exceeds the 0.3 mg/dL threshold)
  • Relative increase: 125% (2.25× baseline, placing it in Stage 2)
  • Fold-change: 2.25 times baseline

This unequivocally qualifies as AKI Stage 2, assuming this rise occurred within the 7-day timeframe specified by KDIGO criteria. 1

Critical Timing Consideration

The diagnosis hinges on when this rise occurred:

  • If within 48 hours: Meets Stage 1 by absolute criteria (>0.3 mg/dL rise) and Stage 2 by relative criteria
  • If within 7 days: Meets Stage 2 criteria by relative increase
  • If beyond 7 days: May represent chronic kidney disease progression rather than AKI

Clinical Significance

This magnitude of creatinine rise is clinically significant and associated with increased mortality. Studies demonstrate that even smaller rises (≥0.3 mg/dL) are independently associated with approximately fourfold increase in hospital mortality 1. Your patient's larger rise carries substantial prognostic implications for morbidity and mortality.

Common Pitfalls to Avoid

  1. Volume status confusion: Significant fluid resuscitation can dilute creatinine, potentially masking the true severity of kidney injury 2. If your patient received substantial IV fluids, the actual GFR decline may be worse than the creatinine suggests.

  2. Missing baseline: If 0.8 mg/dL wasn't a true baseline but rather an admission value, you may need to estimate baseline using MDRD equation assuming GFR of 75 ml/min per 1.73 m² 1, 2.

  3. Chronic kidney disease patients: In CKD patients, KDIGO criteria can classify rises differently. However, your baseline of 0.8 mg/dL suggests normal kidney function, making this clearly acute 1.

  4. Transient vs. persistent: Even if creatinine rapidly returns to normal, the AKI diagnosis stands and carries prognostic significance for outcomes 3.

References

3
Research

Rapid reversal of acute kidney injury and hospital outcomes: a retrospective cohort study.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2009

Related Questions

If a patient's serum creatinine rises from 1.0 mg/dL to 1.30 mg/dL, does this meet criteria for acute kidney injury and what immediate management steps are recommended?
Why does acute kidney injury cause an elevated serum creatinine level?
What are the serum creatinine criteria for diagnosing acute kidney injury and how should creatinine be monitored?
In a CKD patient with baseline serum creatinine of 360 µmol/L, does an increase of >26 µmol/L indicate AKI Stage 1?
In a 77-year-old patient whose serum creatinine increased from 0.8 mg/dL to 1.7 mg/dL, does this meet AKIN (Acute Kidney Injury Network) Stage II criteria?
What is the evidence linking microplastic exposure to low testosterone, and how should low testosterone be evaluated and managed?
In a complex psychiatric patient currently taking atomoxetine 40 mg, venlafaxine 15 mg, aripiprazole (dose unspecified), and prn gabapentin 100–200 mg, who remains anxious and disorganized while awaiting intensive outpatient program (IOP), is initiating olanzapine (Zyprexa) 2.5 mg appropriate?
In a 26‑year‑old woman with polymenorrhea who has not responded to Nexstellis and has a normal pelvic ultrasound, is there a combined oral contraceptive with a higher progestin dose that would be more favorable?
Does free thyroxine (free T4) or total thyroxine (total T4) cause bradycardia?
In a 16-year-old male with hypocalcemia who has an electrocardiogram showing sinus rhythm, PR interval 122 ms, QRS duration 67 ms, QTc 414‑427 ms, P‑wave, QRS and T‑wave axes of 12°, 76° and 37°, inferior ST‑segment elevation with reciprocal precordial ST‑segment depression, what is the appropriate next step in management?
What is the appropriate treatment for a typical adult presenting with unilateral red eye, watery discharge, foreign‑body sensation, and no bacterial signs, suggestive of a viral etiology such as adenoviral conjunctivitis or herpes simplex virus keratitis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.